Company Search:
Advanced Search
Sponsored Links
YSP Southeast Asia Holding Bhd Company Snapshot
YSP Southeast Asia Holding Bhd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares YSP Southeast Asia Holding Bhd with three other companies in this sector in Malaysia: CCM Duopharma Biotech Berhad (2017 sales of 467.99 million Malaysian Ringgits [US$112.69 million] of which 100% was Manufacturing of Pharmaceutical Products), Kotra Industries Bhd (166.37 million Malaysian Ringgits [US$40.06 million] ), and Hovid Berhad (169.94 million Malaysian Ringgits [US$40.92 million] ).

Sales Analysis. YSP Southeast Asia Holding Bhd reported sales of 261.56 million Malaysian Ringgits (US$62.98 million) for the year ending December of 2017. This represents an increase of 10.3% versus 2016, when the company's sales were 237.07 million Malaysian Ringgits. Sales at YSP Southeast Asia Holding Bhd have increased during each of the previous five years (and since 2012, sales have increased a total of 45%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
YSP Southeast Asia Holding Bhd
  Stock Performance Chart for YSP Southeast Asia Holding Bhd
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 3.07
(Figures in Malaysian Ringgits)
1 Week -7.0%   13 Weeks 3.0%  
4 Weeks 20.9%   52 Weeks 4.1%  
YSP Southeast Asia Holding Bhd Key Data:
  Ticker: YSPSAH Country: Malaysia
  Exchanges: KUL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 261,556,000
(Year Ending Jan 2018).
Employees: 519
  Currency: Malaysian Ringgits Market Cap: 424,516,530
  Fiscal Yr Ends: December Shares Outstanding: 138,279,000
  Share Type: Ordinary Closely Held Shares: 92,103,981
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.